Bozkurt A - Search Results

1

CYP2C19 genotype does not represent a genetic predisposition in idiopathic systemic lupus erythematosus.

Kortunay S, Bozkurt A, Bathum L, Basci NE, Calgüneri M, Brøsen K, Kayaalp SO. Kortunay S, et al. Among authors: bozkurt a. Ann Rheum Dis. 1999 Mar;58(3):182-5. doi: 10.1136/ard.58.3.182. Ann Rheum Dis. 1999. PMID: 10364917 Free PMC article.

2

S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.

Basci NE, Brosen K, Bozkurt A, Isimer A, Sayal A, Kayaalp SO. Basci NE, et al. Among authors: bozkurt a. Br J Clin Pharmacol. 1994 Nov;38(5):463-5. doi: 10.1111/j.1365-2125.1994.tb04383.x. Br J Clin Pharmacol. 1994. PMID: 7893589 Free PMC article. Clinical Trial.

3

Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population.

Basci NE, Bozkurt A, Kortunay S, Isimer A, Sayal A, Kayaalp SO. Basci NE, et al. Among authors: bozkurt a. Br J Clin Pharmacol. 1996 Dec;42(6):771-3. doi: 10.1046/j.1365-2125.1996.00500.x. Br J Clin Pharmacol. 1996. PMID: 8971434 Free PMC article. Clinical Trial.

4

The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism.

Kortunay S, Basci NE, Bozkurt A, Isimer A, Sayal A, Kayaalp SO. Kortunay S, et al. Among authors: bozkurt a. Eur J Clin Pharmacol. 1997;53(3-4):261-4. doi: 10.1007/s002280050373. Eur J Clin Pharmacol. 1997. PMID: 9476042

5

CYP2D6 polymorphism in systemic lupus erythematosus patients.

Kortunay S, Bozkurt A, Bathum L, Basci NE, Calgüneri M, Brøsen K, Kayaalp SO. Kortunay S, et al. Among authors: bozkurt a. Eur J Clin Pharmacol. 1999 Mar;55(1):21-5. doi: 10.1007/s002280050587. Eur J Clin Pharmacol. 1999. PMID: 10206080 Clinical Trial.

6

N-acetylation phenotyping with sulphadimidine in a Turkish population.

Bozkurt A, Basci NE, Kalan S, Tuncer M, Kayaalp SO. Bozkurt A, et al. Eur J Clin Pharmacol. 1990;38(1):53-6. doi: 10.1007/BF00314803. Eur J Clin Pharmacol. 1990. PMID: 2328748

7

Sulphamethoxazole acetylation in fast and slow acetylators.

Bozkurt A, Basci NE, Isimer A, Tuncer M, Erdal R, Kayaalp SO. Bozkurt A, et al. Int J Clin Pharmacol Ther Toxicol. 1990 Apr;28(4):164-6. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2338369

8

Correlation between the metabolic ratios of debrisoquine and metoprolol in Turkish subjects.

Basci NE, Bozkurt A, Isimer A, Kayaalp SO. Basci NE, et al. Among authors: bozkurt a. Pharmacol Toxicol. 1994 Jul;75(1):62-4. doi: 10.1111/j.1600-0773.1994.tb00325.x. Pharmacol Toxicol. 1994. PMID: 7971736 No abstract available.

9

Polymorphic debrisoquin metabolism in a Turkish population.

Bozkurt A, Basci NE, Isimer A, Sayal A, Kayaalp SO. Bozkurt A, et al. Clin Pharmacol Ther. 1994 Apr;55(4):399-401. doi: 10.1038/clpt.1994.48. Clin Pharmacol Ther. 1994. PMID: 8162666

10

Determination of debrisoquine and 4-hydroxydebrisoquine in urine by high-performance liquid chromatography with fluorescence detection after solid-phase extraction.

Bozkurt A, Basci NE, Isimer A, Kayaalp SO. Bozkurt A, et al. J Pharm Biomed Anal. 1993 Aug;11(8):745-9. doi: 10.1016/0731-7085(93)80184-3. J Pharm Biomed Anal. 1993. PMID: 8257740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

589 results

Search Page

Filters